Dario Akaberi
Postdoctoral position at Department of Medical Biochemistry and Microbiology; Infection and Immunity; Åke Lundkvist
- E-mail:
- dario.akaberi@imbim.uu.se
- Visiting address:
- BMC
Husargatan 3
752 37 UPPSALA - Postal address:
- Box 582
751 23 UPPSALA
Publications
Recent publications
-
Part of Frontiers in Immunology, 2025
- DOI for The quantity and quality of B-cell immunity against SARS-CoV-2 in children with cancer and hematological diseases
- Download full text (pdf) of The quantity and quality of B-cell immunity against SARS-CoV-2 in children with cancer and hematological diseases
-
Study on the temporal and spatial distribution of Culex mosquitoes in Hanoi, Vietnam
Part of Scientific Reports, 2024
- DOI for Study on the temporal and spatial distribution of Culex mosquitoes in Hanoi, Vietnam
- Download full text (pdf) of Study on the temporal and spatial distribution of Culex mosquitoes in Hanoi, Vietnam
-
Part of Antimicrobial Agents and Chemotherapy, p. 1-18, 2024
- DOI for Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries
- Download full text (pdf) of Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries
-
Vector competence of Swedish Culex pipiens mosquitos for Japanese encephalitis virus
Part of Parasites & Vectors, 2024
- DOI for Vector competence of Swedish Culex pipiens mosquitos for Japanese encephalitis virus
- Download full text (pdf) of Vector competence of Swedish Culex pipiens mosquitos for Japanese encephalitis virus
-
Identification of protease inhibitors against Flaviviruses and Coronaviruses
2023
All publications
Articles in journal
-
Part of Frontiers in Immunology, 2025
- DOI for The quantity and quality of B-cell immunity against SARS-CoV-2 in children with cancer and hematological diseases
- Download full text (pdf) of The quantity and quality of B-cell immunity against SARS-CoV-2 in children with cancer and hematological diseases
-
Study on the temporal and spatial distribution of Culex mosquitoes in Hanoi, Vietnam
Part of Scientific Reports, 2024
- DOI for Study on the temporal and spatial distribution of Culex mosquitoes in Hanoi, Vietnam
- Download full text (pdf) of Study on the temporal and spatial distribution of Culex mosquitoes in Hanoi, Vietnam
-
Part of Antimicrobial Agents and Chemotherapy, p. 1-18, 2024
- DOI for Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries
- Download full text (pdf) of Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries
-
Vector competence of Swedish Culex pipiens mosquitos for Japanese encephalitis virus
Part of Parasites & Vectors, 2024
- DOI for Vector competence of Swedish Culex pipiens mosquitos for Japanese encephalitis virus
- Download full text (pdf) of Vector competence of Swedish Culex pipiens mosquitos for Japanese encephalitis virus
-
Part of Viruses, 2023
- DOI for Reduced Binding between Omicron B.1.1.529 and the Human ACE2 Receptor in a Surrogate Virus Neutralization Test for SARS-CoV-2
- Download full text (pdf) of Reduced Binding between Omicron B.1.1.529 and the Human ACE2 Receptor in a Surrogate Virus Neutralization Test for SARS-CoV-2
-
Part of Journal of the American Chemical Society, p. 2905-2920, 2022
- DOI for Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses
- Download full text (pdf) of Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses
-
Part of Antiviral Research, 2021
-
Presymptomatic viral shedding and infective ability of SARS-CoV-2: a case report
Part of Heliyon, 2021
- DOI for Presymptomatic viral shedding and infective ability of SARS-CoV-2: a case report
- Download full text (pdf) of Presymptomatic viral shedding and infective ability of SARS-CoV-2: a case report
-
SARS-CoV-2 in hospital indoor environments is predominantly non-infectious
Part of Virology Journal, 2021
- DOI for SARS-CoV-2 in hospital indoor environments is predominantly non-infectious
- Download full text (pdf) of SARS-CoV-2 in hospital indoor environments is predominantly non-infectious
-
Part of Infection Ecology & Epidemiology, 2020
- DOI for Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for 4 assessment of past exposure to SARS-CoV-2
- Download full text 1 (pdf) of Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for 4 assessment of past exposure to SARS-CoV-2
- Download full text 2 (pdf) of Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for 4 assessment of past exposure to SARS-CoV-2
-
Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro
Part of Redox Biology, 2020
- DOI for Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro
- Download full text (pdf) of Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro
-
Part of Journal of Biomolecular Structure and Dynamics, p. 5526-5536, 2020
- DOI for Identification of a C2-symmetric diol based human immunodeficiency virus protease inhibitor targeting Zika virus NS2B-NS3 protease
- Download full text (pdf) of Identification of a C2-symmetric diol based human immunodeficiency virus protease inhibitor targeting Zika virus NS2B-NS3 protease
-
Long-distance airborne dispersal of SARS-CoV-2 in COVID-19 wards
Part of Scientific Reports, 2020
- DOI for Long-distance airborne dispersal of SARS-CoV-2 in COVID-19 wards
- Download full text (pdf) of Long-distance airborne dispersal of SARS-CoV-2 in COVID-19 wards
-
Part of Scandinavian Journal of Gastroenterology, p. 1042-1050, 2019
- DOI for Effect of the baseline Y93H resistance-associated substitution in HCV genotype 3 for direct-acting antiviral treatment: real-life experience from a multicenter study in Sweden and Norway
- Download full text (pdf) of Effect of the baseline Y93H resistance-associated substitution in HCV genotype 3 for direct-acting antiviral treatment: real-life experience from a multicenter study in Sweden and Norway
-
Part of Pathogens and Global Health, p. 210-226, 2018
-
Part of Molecular Phylogenetics and Evolution, p. 58-63, 2018
-
Part of Antiviral Therapy, p. 485-493, 2018
-
Part of Scandinavian Journal of Gastroenterology, p. 1347-1353, 2018
- DOI for Personalized treatment of hepatitis C genotype 1a in Norway and Sweden 2014-2016: a study of treatment outcome in patients with or without resistance-based DAA-therapy.
- Download full text (pdf) of Personalized treatment of hepatitis C genotype 1a in Norway and Sweden 2014-2016: a study of treatment outcome in patients with or without resistance-based DAA-therapy.